Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.19.3
Equity (Details)
9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Stock Options [Member]  
Number of Shares  
Outstanding, Beginning | shares 7,236,101
Cancelled/Expired | shares (1,042,800)
Outstanding, Ending | shares 11,931,801
Exercisable | shares 4,347,257
Weighted Average Exercise Price  
Outstanding, Beginning $ 1.74
Granted 0.27
Cancelled/Expired 0.54
Outstanding, Ending 1.14
Exercisable $ 2.28
Weighted Average Remaining Contractual Term (in years)  
Outstanding, Ending 8 years 3 months 29 days
Exercisable 6 years 8 months 26 days
Aggregate Intrinsic Value  
Outstanding, Beginning | $ $ 6,400
Outstanding, Ending | $ 525
Exercisable | $
Warrant [Member]  
Number of Shares  
Outstanding, Beginning | shares 55,820,876
Granted | shares 42,900,000
Exercised | shares (2,543,826)
Cancelled/Expired | shares (9,841,337)
Outstanding, Ending | shares 86,335,713
Exercisable | shares 86,106,964
Weighted Average Exercise Price  
Outstanding, Beginning $ 1.2
Granted 0.5
Exercised 0.59
Cancelled/Expired 2.8
Outstanding, Ending 0.69
Exercisable $ 0.68
Weighted Average Remaining Contractual Term (in years)  
Outstanding, Beginning 2 years 15 days
Granted 5 years
Outstanding, Ending 3 years 2 months 8 days
Exercisable 3 years 2 months 8 days
Aggregate Intrinsic Value  
Outstanding, Beginning | $ $ 569,038
Outstanding, Ending | $ 322,227
Exercisable | $ $ 322,227